Introduction: The farm-to-table paradigm and the challenge of metabolic health

The European Union is facing an unprecedented public health crisis: the relentless rise in cardiometabolic diseases, including obesity, type 2 diabetes, dyslipidemia, and cardiovascular disease. These silent illnesses not only reduce citizens' healthy lifespan but also jeopardize the viability of healthcare systems. In response to this challenge, the European Commission launched the Farm to Fork strategy within the framework of the European Green Deal, aiming to design a fair, healthy, and environmentally friendly food system.

However, to achieve a real impact on population health, agricultural sustainability must be merged with cutting-edge biomedical science. This is where the concept of [the concept of] [the concept of] precision nutritionIt is not enough to ensure that sustainably produced food is accessible; we must understand how each individual's biological profile reacts to that food. Integrating omics data into the food value chain, from agricultural cultivation to the design of the consumer's plate, represents the frontier of modern cardiometabolic prevention.

The failure of traditional health guidelines

Traditional nutritional guidelines have historically been overly general, dictating uniform macronutrient intakes for the entire population. Research over the last decade has unequivocally demonstrated the failure of this "one-size-fits-all" approach. Two people consuming the same sustainable Mediterranean diet can exhibit radically different metabolic trajectories: one may reduce their LDL cholesterol levels and improve their inflammatory profile, while the other experiences increases in lipid markers and insulin resistance. This interindividual variability, defined by genetics, epigenetics, and the microbiome, demands technological tools capable of personalizing meals to maximize the preventive efficacy of each food.

European projects and the basis of precision science: Preventomics (H2020)

The development of the algorithmic engine and the science behind Oorenji is not the result of corporate improvisation, but the direct outcome of participation in cutting-edge European research consortia, among which the Horizon 2020 project stands out clearly. Preventomics (Empowering prevention of chronic diseases through personalized nutrition).

The Preventomics Consortium: From Research to Clinical Practice

Preventomics, coordinated by prestigious Spanish scientific and academic institutions (including the UIB research group and CIBERobn, led by leading experts in the field), was launched with the scientific objective of demonstrating the viability and clinical efficacy of personalized nutrition. The project developed and validated precise metabolomic and genetic markers integrated into digital platforms, allowing users to receive personalized nutritional recommendations based on their unique biological profile.

The success of Preventomics demonstrated that when people follow dietary guidelines tailored to their specific genetic variants and current metabolic status, adherence to lifestyle changes increases exponentially, and significant improvements occur in markers of inflammation, blood pressure, lipid profile, and body fat percentage. Oorenji (https://oorenji.com) inherits and directly applies this methodology and clinical decision engine, which is supported by the European Union.

Key genetic variants in cardiometabolic prevention

The precision prevention of cardiometabolic diseases is based on the analysis of polymorphisms that modulate lipid transport pathways, inflammation, oxidative stress, and energy balance.

The Apolipoprotein E (APOE) gene and cholesterol metabolism

Apolipoprotein E is a critical ligand for lipoprotein receptors, playing a fundamental role in the clearance of cholesterol and triglycerides from the circulation. The APOE gene has three main alleles (ε2, ε3, and ε4) that give rise to six different genotypes.

• Carriers of the APOE-ε4 risk variant: Individuals with ε4/ε3 or ε4/ε4 genotypes absorb cholesterol in the intestines with exceptional efficiency and exhibit slowed hepatic elimination, which is associated with elevated LDL levels and a significantly higher cardiovascular risk. Nutrigenetics reveals that ε4 carriers respond very erratically to diets high in saturated fat, experiencing severe cholesterol spikes. However, they show an excellent risk-reducing response to diets rich in soluble fiber, unsaturated fats, and antioxidants.

The MTHFR gene: Homocysteine and endothelial integrity

The MTHFR (Methylenetetrahydrofolate reductase) gene encodes a key enzyme in the folate cycle and homocysteine metabolism.

• The C677T risk variant: Individuals homozygous for the C677T variant (TT genotype) exhibit significantly reduced enzyme activity, which can lead to elevated blood homocysteine levels. High levels of homocysteine directly damage the endothelium of arteries, increasing the risk of atherosclerosis and thrombosis. Precision nutrition allows for the detection of this genotype, enabling the prioritization of diets rich in bioavailable folates (green leafy vegetables, legumes) or personalized supplementation with methylated folate (L-methylfolate), proactively restoring homeostasis and protecting the endothelium.

Oorenji: Clinical translation from farm to table

Oorenji's advanced platform (https://oorenji.com) bridges the gap between sustainable food production of the Farm2Fork strategy and the individual biology of the consumer, providing an interactive and precise channel for healthcare.

Nutritional personalization based on real science

Oorenji's engine doesn't just suggest generic healthy dishes. It processes the user's genetic information, their reported symptoms, and their metabolic goals:

• It automatically designs personalized menus based on locally sourced ingredients, reducing the carbon footprint and maximizing the density of micronutrients needed according to your DNA (e.g., increasing polyunsaturated fats in APOE-ε4 carriers or natural folates for MTHFR-677TT).
• It provides nutrition professionals with a clinical control panel (Caloo Pro) where they can visualize this molecular data in a synthesized and practical way to prescribe guidelines with the maximum clinical evidence.
• It facilitates the adoption of sustainable habits by directly linking individual health with environmental respect, inextricably linking precision nutrition with the planet's sustainable food future.

Conclusion: Your genome as a preventative compass

The fight against cardiometabolic diseases isn't won by indiscriminately restricting entire food groups or following the latest viral internet diet. It's won with precision. Your genome is the ultimate preventative compass.

Oorenji's active participation in European research projects like Preventomics and its strategic alignment with Farm2Fork policies allow us to offer a health tool with the highest scientific rigor. Taking control of your diet, guided by your genetics with Oorenji, is the most transformative step you can take today to protect your heart, optimize your metabolism, and give yourself a future of lasting well-being backed by cutting-edge science.

Scientific references

• European Commission. (2020). A Farm to Fork Strategy for a fair, healthy and environmentally-friendly food systemBrussels.
• Preventomics Project. (2022). Empowering prevention of chronic diseases through personalized nutrition. European Union Horizon 2020.
• Ordovas, JM, Ferguson, LR, Tai, ES, & Mathers, JC (2018). Personalized nutrition and health. BMJ, 361, k2173.
• Corella, D., & Ordovas, J.M. (2005). Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annual Review of Nutrition, 25, 341-390.
• Palou, A., & Palou, M. (2021). Nutrigenomics and nutrigenetics: the clinical translation of precision nutrition. Journal of Clinical Medicine, 10(12), 2611.